Panacea Biotec Limited — New Orders, 23-04-2025: Bagging/Receiving of orders/contracts

Panacea Biotec Ltd has received an additional award from UNICEF for the supply of 40 million doses of its bivalent oral polio vaccine (bOPV), valued at approximately US$ 5.20 million (around Rs. 44 Crore), to be executed in Q3 CY2025. This follows an earlier communication regarding a contract for 115 million doses worth approximately US$ 14.95 million (around Rs. 127 Crore) in the same calendar year. The arrangement with UNICEF is expected to be amended accordingly, reflecting this latest addition. This development underscores Panacea's ongoing relationship with UNICEF and the potential for sustained revenue from global health initiatives, marking a positive outlook for the company’s future growth in the vaccine market. Investors should watch closely as this could enhance Panacea's market positioning and strengthen its financial performance.